Relief Therapeutics to Participate in Virtual Investor Conferences in January

2 years ago

GENEVA, SWITZERLAND / ACCESSWIRE / January 5, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a…

NervGen Pharma Applauds President Biden Signing Defense Bill

2 years ago

Department of Defense now able to Move Forward on Brain Plasticity ResearchCincinnati, Ohio--(Newsfile Corp. - January 4, 2022) - NervGen…

Senseonics Announces Business Updates

2 years ago

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,…

Osmind Expands Senior Leadership Team With Addition of Chief Growth Officer and Scientific Advisory Board Members

2 years ago

Adam Farren Named Chief Growth Officer Maurizio Fava, MD and Boris Heifets, MD, PhD Join Scientific Advisory Board SAN FRANCISCO--(BUSINESS…

Rob Cohen Named CEO at Bamboo Health

2 years ago

LOUISVILLE, Ky.--(BUSINESS WIRE)--Bamboo Healthâ„¢, formerly Appriss Health and PatientPing, a healthcare technology solutions company focused on fostering care collaboration and…

POM Medical, LLC signs Exclusive International Distribution Agreement with Mercury Medical(R) Expanding its Commercial Presence Beyond the US Market

2 years ago

CLEARWATER, FL / ACCESSWIRE / January 4, 2022 / POM Medical, LLC has expanded their Mercury Medical US Distribution Partnership…

The Drug Delivery Company Receives 4th patent for Its Bio Absorbable Drug Delivery System, Moving it Closer to Its Goal of Helping to Slow the Opioid (Fentanyl) Overdose Crisis

2 years ago

SALISBURY, MD / ACCESSWIRE / January 4, 2022 / The Drug Delivery Company, LLC, a research and development company that…

Champions Oncology Announces a Partnership with Alloy Therapeutics to Develop Therapeutic Monoclonal Antibodies for Use in ADC Programs

2 years ago

HACKENSACK, NJ / ACCESSWIRE / January 4, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is…

Jaguar Health Launches Canalevia-CA1 (Crofelemer) for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

2 years ago

The Canalevia.com website, a resource for veterinarians and dog owners, is now liveCanaleviaâ„¢-CA1 is the first and only treatment for…

Viveve to Participate in H.C. Wainwright BIOCONNECT Conference

2 years ago

ENGLEWOOD, CO / ACCESSWIRE / January 4, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's…